Published in Curr Stud Hematol Blood Transfus on January 01, 1994
A potential RNA drug target in the hepatitis C virus internal ribosomal entry site. RNA (2000) 1.75
Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen. Genet Vaccines Ther (2009) 0.93
Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes. Clin Vaccine Immunol (2010) 0.89
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet (1990) 8.56
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med (1989) 8.10
Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature (1986) 7.38
Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology (1991) 7.33
Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end. Proc Natl Acad Sci U S A (1991) 7.13
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol (1992) 6.09
The Health On the Net Code of Conduct for medical and health Websites. Comput Biol Med (1998) 5.17
Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology (1991) 4.47
A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan. Nucleic Acids Res (1989) 4.29
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77
Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A (1994) 3.76
Multienzyme systems of DNA replication. Science (1974) 3.66
Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet (1989) 3.42
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci U S A (1996) 3.25
Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol (1993) 3.18
A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta. J Virol (1988) 2.99
Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. Science (1983) 2.97
Nucleotide sequence of core and envelope genes of the hepatitis C virus genome derived directly from human healthy carriers. Nucleic Acids Res (1990) 2.76
The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun (1993) 2.67
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest (1995) 2.66
Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol (1993) 2.58
Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology (1992) 2.58
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol (1993) 2.57
Ten proteins required for conversion of phiX174 single-stranded DNA to duplex form in vitro. Resolution and reconstitution. J Biol Chem (1975) 2.48
Hepatitis C antibody and chronic liver disease in haemophilia. Lancet (1990) 2.44
Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature (1983) 2.41
T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology (1993) 2.39
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol (2001) 2.34
Structure of two related rat pancreatic trypsin genes. J Biol Chem (1984) 2.24
Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc Natl Acad Sci U S A (1992) 2.18
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci U S A (1990) 2.12
Hepatitis C viral cDNA clones isolated from a healthy carrier donor implicated in post-transfusion non-A, non-B hepatitis. Gene (1990) 2.12
Hepatitis C-associated hepatocellular carcinoma. Hepatology (1990) 2.07
Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci U S A (1996) 2.02
Intrafamilial transmission of hepatitis C virus. Lancet (1989) 1.90
Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma. J Clin Microbiol (1991) 1.87
Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet (1990) 1.83
Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet (1989) 1.82
Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene. J Virol (2000) 1.69
Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol (1993) 1.57
The Minnesota Senior Health Options program: an early effort at integrating care for the dually eligible. J Gerontol A Biol Sci Med Sci (2001) 1.57
Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. JAMA (1990) 1.55
Activation of the grp78 and grp94 promoters by hepatitis C virus E2 envelope protein. J Virol (1999) 1.52
Hepatitis C virus replication in 'autoimmune' chronic hepatitis. J Hepatol (1991) 1.52
Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification. Gastroenterology (1992) 1.50
5' end-dependent translation initiation of hepatitis C viral RNA and the presence of putative positive and negative translational control elements within the 5' untranslated region. Virology (1992) 1.45
A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer (1991) 1.45
A discordant sibship analysis between beta-NGF and neurofibromatosis. Am J Hum Genet (1985) 1.44
Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology (1993) 1.41
Health On the Net automated database of health and medical information. Int J Med Inform (1997) 1.29
Another bridge between kingdoms: tRNA splicing in archaea and eukaryotes. Cell (1997) 1.25
The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol (1991) 1.24
Risk factors in hepatitis C virus-infected blood donors. Transfusion (1991) 1.22
Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution. Virology (1994) 1.21
Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology (1997) 1.20
Parenterally transmitted non-A, non-B hepatitis: virus-specific antibody response patterns in hepatitis C virus-infected chimpanzees. Gastroenterology (1990) 1.20
Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet (1993) 1.17
Retinal lesions in subacute sclerosing panencephalitis. Arch Ophthalmol (1970) 1.15
HCV testing in low-risk population. Lancet (1990) 1.14
Blood screening for non-A, non-B hepatitis by hepatitis C virus antibody assay. Transfusion (1990) 1.12
Early antihepatitis C virus response with second-generation C200/C22 ELISA. Vox Sang (1992) 1.08
Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. J Virol (1994) 1.07
Identification of the major, parenteral non-A, non-B hepatitis agent (hepatitis C virus) using a recombinant cDNA approach. Semin Liver Dis (1992) 1.02
Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. Proc Natl Acad Sci U S A (1992) 1.00
The matrix model of outpatient stimulant abuse treatment: history and description. J Psychoactive Drugs (2000) 1.00
Oral sex, crack smoking, and HIV infection among female sex workers who do not inject drugs. Am J Public Health (1997) 0.99
Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus. Vox Sang (1992) 0.96
Iris pigmentation and extent of disease in patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (1994) 0.95
Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%. Am J Ophthalmol (2001) 0.94
The biosynthesis and processing of proteins in the mouse 7S nerve growth factor complex. Cold Spring Harb Symp Quant Biol (1983) 0.94
Two forms of neuronal actin. J Neurochem (1978) 0.93
The Health On the Net Code of Conduct for medical and health web sites. Stud Health Technol Inform (1998) 0.92
Hepatitis C virus antibodies in acute icteric and chronic non-A, non-B hepatitis. Gastroenterology (1991) 0.90
High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration. Ophthalmology (1998) 0.90
Impacts associated with special care units in long-term care facilities. Gerontologist (1990) 0.89
Role of hepatitis C virus in non-B chronic liver disease. Arch Intern Med (1991) 0.86
Clinical response to short-term nasogastric feeding in infants with gastroesophageal reflux and growth failure. J Pediatr Gastroenterol Nutr (1983) 0.86
Vimentin and 70K neurofilament protein co-exist in embryonic neurones from spinal ganglia. J Neurochem (1982) 0.86
Clinicopathologic report of spontaneous expulsive hemorrhage. Ann Ophthalmol (1987) 0.85
Analysis of genomic variability of hepatitis C virus. J Hepatol (1991) 0.85
Antibody to the hepatitis C virus in acute hepatitis and chronic liver diseases in Japan. Liver (1991) 0.83
Hepatitis delta (delta) cDNA clones: undetectable hybridization to nucleic acids from infectious non-A, non-B hepatitis materials and hepatitis B DNA. J Med Virol (1987) 0.82
Elevated serum alanine aminotransferase levels in blood donors: the contribution of hepatitis C virus. Ann Intern Med (1991) 0.82
RNA editing. In search of a template. Nature (1988) 0.81
Retinyl ester hydrolase of bovine retina and pigment epithelium: comparisons to the rat liver enzyme. Curr Eye Res (1985) 0.80
Evaluation of continuing education for long-term care personnel: impact upon attitudes and knowledge. J Am Geriatr Soc (1981) 0.80
Suicidal behavior in latency-age psychiatric inpatients: a replication and cross validation. J Am Acad Child Psychiatry (1982) 0.79
Psychopathology and plasma cortisol responses to dexamethasone in prepubertal psychiatric inpatients. Biol Psychiatry (1989) 0.78
Doxepin versus diazepam: a controlled evaluation in 100 chronic alcoholic patients. J Clin Pharmacol J New Drugs (1969) 0.78
Broadband, high spectral resolution 2-D wavelength-parallel polarimeter for Dense WDM systems. Opt Express (2005) 0.78
Quantitative aspects of the metabolic response to pancreatic islet transplantation in rats with severe ketotic diabetes. Metabolism (1976) 0.77
The impact of guidelines on peri-operative antibiotic administration. J Clin Pharm Ther (1991) 0.77
An in vivo and in vitro investigation of the phototoxic potential of tenoxicam, a new non-steroidal anti-inflammatory agent. Dermatologica (1987) 0.76
Prospects for prophylactic and therapeutic hepatitis C virus vaccines. Princess Takamatsu Symp (1995) 0.75
Phones for the disabled. Nurs Mirror (1977) 0.75